Butterfly Network, Inc.

NYSE: BFLY·Burlington, Massachusetts·

Price
$5.71
Base IV
$0.60

Valuation snapshot

Above bull case

At $5.71, the price is above even our bull case of $2.10.

Values per share, from an .

No growth
…
Loading earnings power
Base case
$0.60
10% of the price · range $0.03–$2.10
Price vs base case
859% above
$5.71 against $0.60
Base casevalued by DCF
Price vs base
Priceclose 11‑16

The price has fallen 24.0% since this valuation was struck on 2026-10-30, so some of the gap opened up after these figures were set.

Whisker on the base case runs bear $0.03 to bull $2.10. Values per share.

Price against each value

Bear case
$0.03
Price 16,530% above
No growth
…
—
Base case
$0.60
Price 859% above
Researched bygpt-6-sol
Valuation Oct 30, 2026 · Price as of Nov 16, 2026How we got here

What does Butterfly Network do?

Butterfly Network makes handheld ultrasound probes and companion apps that let clinicians image a patient's heart, lungs, or abdomen at the bedside on a phone or tablet instead of booking an imaging suite.

It brought in $123.3M of sales in the 12 months to Sep 2026.

Led by Joseph M. DeVivo, President, Chief Executive Officer, and Chairman of the Board since 2023. Form 8-K Current Report

Butterfly iQ3 handheld ultrasound probeImage: Butterfly Network
Industry
Healthcare
Based in
Burlington, Massachusetts
Trades on
NYSE as BFLY

Here is where each dollar a customer pays ends up. For every $1 of sales in the 12 months to Sep 2026, it spent about $1.44, so it lost 44¢ on each dollar. The biggest cost is sales, marketing and admin, 74¢ of every dollar.

$1 of sales
  • Making what it sells30¢
  • Research and development32¢
  • Sales, marketing and admin74¢
  • Everything else it takes to operate11¢
  • Interest and other income came back in+3¢
  • Lost on each dollar−44¢
Totals of the four quarters to Sep 2026, from the company's own filings. The split by product is from the latest fiscal year.

Who pays Butterfly Network, and for what?

Butterfly Network makes handheld ultrasound scanners that plug into a smartphone or tablet. Most of its scanners use its own 'Ultrasound-on-Chip' semiconductor. It earns money in three ways: selling the scanners and a cart, charging yearly subscriptions for its imaging and hospital software, and licensing its chip technology to partners such as Midjourney under its 'Butterfly Embedded' program.

Most revenue comes from U.S. hospitals and health systems, individual doctors and other clinicians, medical schools, and veterinarians, with smaller amounts from international distributors, global health groups and technology partners that license its chip.

  • Product

    65%

    Sales of handheld ultrasound probes (iQ3, iQ+, and the bladder and vet versions) and the Butterfly Move cart, plus some deliveries of chips to a technology partner.

    Butterfly iQ3 handheld ultrasound probeImage: Butterfly Network
  • Software and other services

    35%

    Yearly software subscriptions for individual users, the Compass hospital software platform, education offerings, and licensing fees from Butterfly Embedded chip partnerships. Licensing drove most of the 2025 growth in this line.

Share of the latest fiscal year's sales, as the company reports it.

Where its work physically happens, beyond headquarters:

  • Benchmark Ayutthaya Plant — Bang Pa-in, Thailand. This contract-manufacturing site produces, tests, and ships many Butterfly probes, making it central to product supply and exposing Butterfly to single-manufacturer concentration risk.
See them on the globe

Butterfly Network 10-K for fiscal year 2025

How is the business doing?

Sales grew from $46.3M in 2020 to $97.6M in 2025, about 16% a year.

It still spends more to run the business than it brings in: an operating loss of 47¢ per sales dollar, narrower than $3.49 in 2020.

It used $27.6M more cash than it generated in the 12 months to Sep 2026, paid for out of savings or new money.

Sales$97.6M
20202025
Operating margin-89%
20202025
Free cash flow-$16M
20202025
Each bar is one fiscal year (2020–2025), summed from four published quarters; the latest is highlighted.

What does management say it's aiming for?

Butterfly says it exists to make ultrasound imaging available and useful wherever patients receive care, not just in hospital imaging departments.

“democratize healthcare by increasing access and use of ultrasound information wherever care is being delivered”

Butterfly Network 10-K for fiscal year 2025

Who is responsible for the plan?

Roles checked November 14, 2026.

What management says it is working on now:

  • Grow the core hospital and clinician business

    Management wants more health systems and medical schools to use its handheld probes at the bedside, backed by its Compass software, which helps hospitals manage ultrasound across many departments.

    Butterfly Network 10-K for fiscal year 2025
  • License the chip to other companies

    Through Butterfly Embedded, the company licenses its ultrasound chip to partners working in markets that don't compete with its own. Embedded revenue rose to $10.8 million in Q2 2026 from $2.0 million a year earlier, mainly because of the Midjourney partnership.

    Butterfly Network 10-Q for quarter ended June 30, 2026
  • Expand into home care and veterinary markets

    The company is preparing its first commercial Home & Community Care rollout for the second half of 2026 and is selling a vet version of its newest probe in about 20 international markets.

    Butterfly Network Q2 2026 results press release (8-K Exhibit 99.1)
  • Build a network of AI partners and next-generation chips

    Its 'Butterfly Garden' program lets outside developers build AI tools for its devices, and three partner tools are expected to go on sale by year-end. Management also lists a next-generation probe and new P5 and Apollo chips as upcoming launches, without giving dates.

    Butterfly Network Q2 2026 results press release (8-K Exhibit 99.1)
  • Keep spending under control

    Management lists financial discipline as a core part of its strategy. It wants to narrow losses, and it expects higher-margin software to make up a larger share of revenue over time.

    Butterfly Network 10-K for fiscal year 2025
Revenue, Full year 2026
$119 million to $123 million (about 22% to 26% growth)
Butterfly Network Q2 2026 results press release (8-K Exhibit 99.1)
Adjusted EBITDA, Full year 2026
Loss of $19 million to $23 million
Butterfly Network Q2 2026 results press release (8-K Exhibit 99.1)
Goals in management's own numbers. A target is a promise, not a result.

What's changing right now?

Growth is picking up. In Q3 2026 it sold 52% more than a year earlier. The year before, quarters averaged 27%.

Its operating margin is wider than a year ago: a loss of 42¢ per sales dollar, against a loss of $1.63.

Since Jul 2026 the share price has fallen 26%, from $7.75 to $5.71.

Bull $2.10Base $0.60Bear $0.03Jul 16Nov 16 · $5.71
Daily closing prices we have recorded, set against our bear-to-bull range. Our price records start July 16, 2026.

Recently

Coming up

Our own estimate moved too: the base case went from $0.64 to $0.60 a share between our last two valuations. The biggest reason: Software and services revenue, quarterly moved from an unreported prior value to $17.0M, as reported in Butterfly Q3 2026 results.

What could go wrong?

No business is a sure thing. These are the risks we found, starting with the ones the company itself names. Where a risk would change part of the valuation, it says which.

  1. Still losing money

    Butterfly lost $77.1 million in 2025 and says it expects losses to continue for several years. Its cash fell from $150.5 million at the end of 2025 to $124.7 million by June 2026.

    From the company's own filingsWould hit how much of each sale it keepsButterfly Network 10-Q for quarter ended June 30, 2026

  2. Growth depends heavily on a few licensing partners

    Much of the recent growth came from chip licensing, mainly Midjourney, and one customer made up more than 10% of revenue in the latest quarter. If a partner leaves or pays less, revenue could drop sharply.

    From the company's own filingsWould hit how fast sales growButterfly Network 10-Q for quarter ended June 30, 2026

  3. Reliance on a small number of suppliers

    Key parts come from limited or single suppliers. Its contracts with chipmaker TSMC, manufacturer Benchmark and distributor Cardinal Health all come up in 2026, and any disruption could delay or raise the cost of making probes.

    From the company's own filingsWould hit how much of each sale it keepsButterfly Network 10-K for fiscal year 2025

  4. Strong competition and fast-changing technology

    Butterfly competes with larger medical device companies, and new technology could make its devices outdated. Hospital buying groups have also pushed prices down.

    From the company's own filingsWould hit how fast sales growButterfly Network 10-K for fiscal year 2025

  5. Medical and data regulation

    Its products need approvals from health regulators such as the FDA, and new uses like at-home scanning may require clinical trials. Privacy, cybersecurity and responsible-AI rules add cost and legal risk.

    From the company's own filingsWould hit how fast sales growButterfly Network 10-K for fiscal year 2025

  6. Ongoing lawsuits

    The company faces a securities class action, shareholder lawsuits and other litigation. Legal costs were a large part of its $3.6 million in 'other' expenses in Q2 2026.

    From the company's own filingsWould hit how much of each sale it keepsButterfly Network 10-Q for quarter ended June 30, 2026

  7. Product revenue grew only from $14.6 million to $15.6 million between the third quarters of 2025 and 2026.

    From our researchWould hit how fast sales growButterfly Q3 2026 results

  8. Share count is still growing

    Diluted shares grew 5.7% year on year. This valuation uses today's share count, not tomorrow's — continued dilution would spread the same value across more shares.

    From the numbers

Is it a good business?

From 2021 to 2025 it earned between -61% and -7% on its shareholders' equity, a median of -43%.

Over 6 years its operating margin ranged from $3.49 to 89¢ per sales dollar, a median of $2.42. Gross margin ran from $1.32 to 60¢.

derived computed from the filingsassumption cost of capital from the latest valuation
Return on equity-39%
20202025
Return on invested capital is operating profit after tax (at the median effective rate, —) over debt plus equity less cash at each fiscal year end. Return on equity is net income over equity. Both are computed from published quarters.

It bought back shares: the count fell 76% from 2021 to 2025, so each remaining share owns a bigger slice.

What might it be worth?

Net debt is excluded: The reported balance sheet does not yet establish a complete debt figure. The per-share value may change when resolved. No earlier published debt figure is available.

The Valuation snapshot at the top of this page shows the answer. This is how we got there. A share is a slice of the business, so what a share is worth depends on what the business can earn for its owners from here on. We estimate that three ways, from cautious to hopeful, and call the result .

Today a share costs $5.71. Our put its value between $0.03 and $2.10, with $0.60 in the middle. Underneath sit two simpler checks: what it would cost to rebuild the business, its , and what today's profit is worth with no growth at all, its .

Bear case, $0.03

Despite a strong recent rise in sales, this scenario assumes new partnerships bring uneven revenue and the company only barely becomes profitable.

Base case, $0.60

Following strong recent sales growth but continuing losses, this scenario assumes partnerships keep sales rising while the larger business gradually becomes profitable.

Bull case, $2.10

After a sharp recent rise in sales, this scenario assumes new partners and larger customers keep sales growing quickly and turn the company into a strongly profitable business.

Another way in: instead of asking what the business is worth, ask what today's price assumes it will do.

Why the gap?

The price expects far more than we do.Price above value: 859%

For Butterfly Network to be worth today's $5.71, sales would need to grow about 88.2% a year. We assume 15.4%. Over the last 5 years, sales grew 15.8% a year.

−20%0%+20%+40%+60%+80%+100%We assume 15.4%Past 5 yrs 15.8%Price needs 88.2%

Keep in mind: investors are likely paying for things this model leaves out, such as new businesses or many more years of fast growth.

Do you think sales can grow 88.2% a year?

Try your own numbers

We're not very sure of this range: it scores 37 out of 100 on our checks. The weakest point is scenario dispersion.

Test the assumptions

Our base value of $0.60 rests on three assumptions. Change any of them to see how the value per share responds.

  • Revenue growth, 5-year average15.4%
  • Operating margin14.0%
  • Long-term growth rate2.5%

This is an educational explanation built from public filings and our own research, not investment advice. It does not tell you whether to buy or sell anything.

Base estimate

$0.60 -89.6%

Build